Ananda Pharma Plc (AQSE:ANA, OTCQB:ANANF) is gearing up for its first clinical trial in Australia after finishing drug development on its CBD-based treatment. Two former GW Pharma execs have joined to help push things forward.
Accsys Technologies Plc (LSE:AXS, AEX:AXS, OTC:ACSYF) says demand is strong for its sustainable building products, with sales up 13% and North America leading growth. The company’s acetylation tech gives it an edge, and it's on track to meet market expectations.
Autonomix Medical Inc (NASDAQ:AMIX) has wrapped up phase one of its trial treating pancreatic cancer pain using radiofrequency ablation. Some patients saw pain relief within 24 hours, with no serious side effects reported.
Bitcoin is back above $100,000, and Bitwise Asset Management says inflation fears and dollar doubts are driving demand. Over 101,000 bitcoins have been scooped up by listed companies as treasury assets so far this year, more than twice the supply.
